Glaucoma Trial, Recruiting NCT07354009 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Glaucoma
Back to Glaucoma

Glaucoma Trial, Recruiting

NCT07354009
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older (any gender)
  • You have been diagnosed with open-angle glaucoma in the eye being studied
  • You have been diagnosed with cataracts in the eye being studied and are considered a suitable candidate for cataract removal surgery, with vision in that eye at a certain level of impairment (or your doctor has decided you need cataract surgery even if your vision is better than that level)
  • A special eye examination has confirmed that the drainage angle in your eye is open and healthy, with no abnormalities that could affect the placement of a small device (confirm with trial site)
  • You are able and willing to sign a consent form and attend all required follow-up appointments after surgery

Who may not be able to join:

  • You have a type of glaucoma other than open-angle glaucoma, such as angle-closure, pigmentary, or pseudo-exfoliative glaucoma
  • Your glaucoma was caused by an injury, severe eye inflammation, abnormal blood vessel growth, or certain blood vessel-related conditions
  • You have serious eye conditions such as severe diabetic eye disease, a detached retina, blocked blood vessels in the retina, or macular degeneration or swelling that could affect the safety of surgery
  • You have a known abnormality in the structure of the front part of your eye that you were born with
  • You have significant corneal disease, active eye inflammation, or have had previous eye surgery that may make measuring eye pressure unreliable
  • You have certain conditions affecting the area around the eye or elsewhere in the body that may raise pressure in the veins around the eye, such as a tumour behind the eye, thyroid eye disease, or Sturge-Weber syndrome (confirm with trial site)
  • You have any eye or general health condition that could make surgery or follow-up examinations unsafe
  • You are pregnant, breastfeeding, planning to become pregnant during the study, or unable to use effective contraception during the study period
  • You are unable or unwilling to follow the medical instructions given during the trial
  • Your doctor has determined for any other reason that you are not suitable to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kaijun Wang, Eye Center, the 2nd Affiliated Hospital, Medical College of Zhejiang Universit

Phone: +86 0571 87783759

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
7 October 2025
Est. completion
1 October 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

intraocular pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov